Search research articles
Contact Us
Filters
Showing results (641-650 of 706) with videos related to
Page
of 71
Sort By:
Heart, Lung & Circulation
|
January 8, 2026
Corrigendum to: "Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations" [Heart Lung Circ. 32(3) (2023) 287-296.]
Natalie C Ward, Gerald F Watts, Warrick Bishop, et al.
Journal of the American Heart Association
|
November 6, 2023
Genome-Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the <i>CETP</i> Gene
Chenglong Yu, Andrew Bakshi, Gerald F Watts, et al.
Nature Communications
|
October 7, 2023
Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts
Habtamu B Beyene, Corey Giles, Kevin Huynh, et al.
Ebiomedicine
|
June 11, 2024
Development and validation of a plasmalogen score as an independent modifiable marker of metabolic health: population based observational studies and a placebo-controlled cross-over study
Habtamu B Beyene, Kevin Huynh, Tingting Wang, et al.
Heart, Lung & Circulation
|
January 27, 2023
Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations
Natalie C Ward, Gerald F Watts, Warrick Bishop, et al.
The Medical Journal of Australia
|
July 28, 2025
Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary
Leon A Adams, William W Kemp, Kate R Muller, et al.
Plos Biology
|
August 28, 2025
Alterations in ether lipid metabolism in obesity revealed by systems genomics of multi-omics datasets
Yvette L Schooneveldt, Sudip Paul, Kevin Huynh, et al.
Journal of Clinical Lipidology
|
April 12, 2025
Developing a national implementation strategy for enhancing the detection of familial hypercholesterolemia: An Australian experience
Mitchell Sarkies, David Sullivan, Andrew Black, et al.
European Heart Journal
|
October 23, 2010
Lipoprotein(a) as a cardiovascular risk factor: current status
Børge G Nordestgaard, M John Chapman, Kausik Ray, et al.
Nature Medicine
|
January 14, 2022
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
Michael J Koren, Patrick Maurice Moriarty, Seth J Baum, et al.
Page
of 71
Search research articles
Search
Showing results (641-650 of 706) with videos related to
Sort By:
Page
of 71
Heart, Lung & Circulation
|
January 8, 2026
Corrigendum to: "Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations" [Heart Lung Circ. 32(3) (2023) 287-296.]
Natalie C Ward, Gerald F Watts, Warrick Bishop, et al.
Journal of the American Heart Association
|
November 6, 2023
Genome-Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the <i>CETP</i> Gene
Chenglong Yu, Andrew Bakshi, Gerald F Watts, et al.
Nature Communications
|
October 7, 2023
Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts
Habtamu B Beyene, Corey Giles, Kevin Huynh, et al.
Ebiomedicine
|
June 11, 2024
Development and validation of a plasmalogen score as an independent modifiable marker of metabolic health: population based observational studies and a placebo-controlled cross-over study
Habtamu B Beyene, Kevin Huynh, Tingting Wang, et al.
Heart, Lung & Circulation
|
January 27, 2023
Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations
Natalie C Ward, Gerald F Watts, Warrick Bishop, et al.
The Medical Journal of Australia
|
July 28, 2025
Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summary
Leon A Adams, William W Kemp, Kate R Muller, et al.
Plos Biology
|
August 28, 2025
Alterations in ether lipid metabolism in obesity revealed by systems genomics of multi-omics datasets
Yvette L Schooneveldt, Sudip Paul, Kevin Huynh, et al.
Journal of Clinical Lipidology
|
April 12, 2025
Developing a national implementation strategy for enhancing the detection of familial hypercholesterolemia: An Australian experience
Mitchell Sarkies, David Sullivan, Andrew Black, et al.
European Heart Journal
|
October 23, 2010
Lipoprotein(a) as a cardiovascular risk factor: current status
Børge G Nordestgaard, M John Chapman, Kausik Ray, et al.
Nature Medicine
|
January 14, 2022
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
Michael J Koren, Patrick Maurice Moriarty, Seth J Baum, et al.
Page
of 71